Results 281 to 290 of about 55,604 (311)

Amyloid-forming property of the N-terminal 1-70 residues of human apolipoprotein A-IV. [PDF]

Sci Rep
Namba N, Danjo T, Kitagawa Y, Naito Y, Ohgita T, Shimanouchi T, Saito H.   +6 more
europepmc   +1 more source

Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease. [PDF]

J Lipid Res
Ao L, van Heemst D, Jukema JW, Rensen PCN, Willems van Dijk K, Noordam R.   +5 more
europepmc   +1 more source

Blood Plasma Markers in Depressed Mice under Chronic Social Defeat Stress. [PDF]

Biomedicines
Smagin DA, Bezryadnov DV, Zavialova MG, Abramova AY, Pertsov SS, Kudryavtseva NN.   +5 more
europepmc   +1 more source

The functions of apolipoproteins and lipoproteins in health and disease. [PDF]

Mol Biomed
Ma Z, Zhong J, Tu W, Li S, Chen J.
europepmc   +1 more source

Risk of Dementia in Non‐Overtly Functional Adrenal Tumours (NOFAT)—Reply

Clinical Endocrinology, EarlyView.
Hadis Mirzaei, Jekaterina Patrova, Buster Mannheimer, Jonatan D. Lindh, Henrik Falhammar   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Apolipoprotein D—An atypical apolipoprotein

Progress in Lipid Research, 1991
The structure of ApoD and its sites of synthesis have been discovered. These characteristics differ from those of the other apolipoproteins. The role of ApoD in the plasma lipoprotein system remains to be discovered, but the recent, rapid increase in our knowledge of this protein suggests that it plays an important role in the homeostasis or ...
Pierre Provost, Philip K. Weech, Nathalie Tremblay, Ross W. Milne, Eric Rassart, Yves L. Marcel, Rino N. Camato   +6 more
openaire   +2 more sources

The apolipoprotein story

Atherosclerosis Supplements, 2006
The importance of different lipid and lipoprotein measurements, including LDL particle concentration and levels of apolipoproteins and triglycerides, in the prediction of future cardiac events continues to be debated. In summary, apo B is a strong, independent predictor of initial and recurrent coronary events, even during statin treatment, and recent ...
Frank M. Sacks, Frank M. Sacks
openaire   +3 more sources

Update on apolipoprotein B

Current Opinion in Lipidology, 2021
Purpose of review The 2019 European Society of Cardiology/European Atherosclerosis Society Guidelines concluded that apolipoprotein B (apoB) was a more accurate measure of cardiovascular risk and a better guide to the adequacy of lipid lowering than low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein ...
Sniderman, A., Langlois, M., Cobbaert, C.   +2 more
openaire   +3 more sources

Apolipoprotein(a) and atherogenesis

Pathology, 1992
Lipoprotein(a) (Lp(a)) consists of a unique apolipoprotein, apolipoprotein(a), (apo(a)) linked by a disulphide bridge to apolipoprotein B of low density lipoprotein (LDL). Apo(a) is homologous with plasminogen and exhibits genetic polymorphism with the commoner phenotypes due to larger forms being associated with lower plasma levels and the less common
openaire   +3 more sources